Quentin Blackford, CEO of iRhythm, talked to Medtech Insight about his company’s plans to bring its Zio long-term cardiac monitoring platform to more patients by building its evidence base and marketing in more countries outside the US.

For more information on iRhythm, cardiac monitoring and ECG technologies, check out these articles at Medtech Insight.

Cardio Conversations: Vektor Addresses ‘Global Health Crisis’ With Arrythmia Mapping

https://medtech.pharmaintelligence.informa.com/MT147825/Cardio-Conversations-Vektor-Addresses-Global-Health-Crisis-With-Arrythmia-Mapping

CMS Proposes National Payments For Long-Term Continuous Electrocardiogram Monitoring

https://medtech.pharmaintelligence.informa.com/MT145597/CMS-Proposes-National-Payments-For-Long-Term-Continuous-Electrocardiogram-Monitoring

FDA Clears iRhythm’s Afib-Detecting Wearable Running Software Co-Developed By Verily

https://medtech.pharmaintelligence.informa.com/MT145646/FDA-Clears-iRhythms-Afib-Detecting-Wearable-Running-Software-Co-Developed-By-Verily

Exec Chat: As Reimbursement Questions Get Answers, iRhythm Looks To The Future

https://medtech.pharmaintelligence.informa.com/MT145401/Exec-Chat-As-Reimbursement-Questions-Get-Answers-iRhythm-Looks-To-The-Future

JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet

https://medtech.pharmaintelligence.informa.com/MT144935/JPM-2022-Abbott-iRhythm-Novocure-Zimmer-Biomet

Exec Chat: New iRhythm CEO Foresees Enormous Opportunity In AI For Arrhythmia Detection

https://medtech.pharmaintelligence.informa.com/MT144913/Exec-Chat-New-iRhythm-CEO-Foresees-Enormous-Opportunity-In-AI-For-Arrhythmia-Detection

Dexcom COO Quentin Blackford Takes CEO Job At iRhythm

https://medtech.pharmaintelligence.informa.com/MT144461/Dexcom-COO-Quentin-Blackford-Takes-CEO-Job-At-iRhythm